EASYLONGER's customer research, drawn from years of direct user interactions, reveals that a substantial share of CPAP users ...

Earlier this week, ResMed (NYSE:RMD) reported that it will release its quarterly earnings on Thursday afternoon, with Wall Street expecting around 10% year-on-year revenue growth and earnings of about ...

The ASX healthcare share's price has softened recently, but the long-term investment case remains firmly intact for patient ...

Discover Singapore-led innovations from global companies, including myopia-slowing lenses and Dyson vacuums, that are ...

Sleep apnoea company Resmed has acquired a California firm that makes a device for patients with restless leg syndrome, the ...

With the stress of daily life for many Floridians, we are seeing less and less good sleeping habits. There are solutions.

By Bageshri Banerjee April 30 (Reuters) - Medical device maker ResMed beat third‑quarter profit estimates on Thursday, driven by strong demand for its medical devices, while appointing Aaron Bloomer ...

Noctrix Health developed and manufactures a novel non-invasive, wearable therapy to treat drug-refractory Restless Leg ...

Resmed CEO Mick Farrell discusses the FDA-cleared artificial intelligence-enabled ‘Smart Comfort’ setting for AirSense 11 ...

A model made using machine learning can predict if CPAP use in patients with obstructive sleep apnea will benefit or harm ...

If you’ve been diagnosed with obstructive sleep apnea (OSA), you’ve probably received a prescription for continuous positive airway pressure (CPAP) therapy. “Continuous positive airway pressure is ...

Providers saw slower sleep patient volume in the last 12 months but expect improved growth in the next 12 months, according to the 1Q26 HME Sleep and Oxygen Survey from Needham.